Leah Kuntz

The first patient in a phase 2/3 study evaluating ulotaront for MDD has been enrolled.

New research finds that a urine test for formic acid could detect early-stage Alzheimer disease.

The phase 3 SERENITY III trial investigating at-home use of dexmedetomidine (BXCL501) sublingual film for agitation associated with bipolar I or II disorder or schizophrenia has started.

Have you missed the latest episodes of the series Tales From the Clinic: The Art of Psychiatry?

A new bill, the Breakthrough Therapies Act, would encourage the reclassification of MDMA and psilocybin from schedule I to schedule II drugs.

The second of a phase 3 study examining MDMA-AT just completed its final participant visit.

We may be one step closer to nonprescription naloxone.

ADHD is an all-day affair, and treating it in an adult population can be difficult.

What is the impact of antipsychotic side effects on medication adherence?

A single dose of psilocybin could help patients with treatment-resistant depression, according to a new study.

Individuals with a psychotic disorder are 2.5 times more likely than those without one to develop dementia.

According to new research, treating depression in older adults could decrease risk of dementia by 51%.

What scares mental health clinicians? We asked, and these brave individuals replied…

How can PMHNP consults with law enforcement reduce involuntary transfers and other unwanted outcomes?

Does the YOI intervention improve mental health workers’ insomnia? Research says yes.

Recent research determined the medications modafinil, atomoxetine, and guanfacine negatively impact bones.

Did you miss the 2022 Annual Psychiatric Times™ World CME Conference? We've got you covered.

Comorbid SUD and ADHD is associated with more severe illness. What do we understand about these comorbid conditions and what do we still need to learn?

A new poll sought to understand the public’s beliefs about mental health and suicide prevention. Here are the results.

The NCCHC and 166 national organizations recently signed a letter to Senate leadership advocating for increased access to buprenorphine.

For the first time, the USPSTF is recommending anxiety screening for adults under 65.

Reading 1 story a day might help those living with suicidal thoughts and behaviors.

The FDA has accepted the NDA for aripiprazole 2-month, ready-to-use, long-acting injectable.

Long-acting injectable haloperidol decanoate may work as a treatment for Adderall-induced persistent psychosis.

A new study finds mood shifts and alcohol-related cues affect men and women differently in terms of alcohol cravings.

The National Commission on Correctional Health Care has issued a new directive for trauma-responsive care for children and adolescents in correctional facilities.

Suicide Prevention Week is September 4-10. Are you ready?

New data shows a decrease in life expectancy in the United States. Here’s why.

This new study is evaluating how effective psychedelics can be in the treatment of binge eating disorder.